Matches in Nanopublications for { ?s ?p "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP857863.RAkVbw5IH7gycK8eWEmAMqPyhsRsGlOJ5DTTchFKeqBjQ130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857863.RAkVbw5IH7gycK8eWEmAMqPyhsRsGlOJ5DTTchFKeqBjQ130_provenance.
- NP591151.RABOSAn_Zp__dXQbKTsCI0RXA04CkK7L135DQEslzY9D4130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591151.RABOSAn_Zp__dXQbKTsCI0RXA04CkK7L135DQEslzY9D4130_provenance.
- NP591155.RADdlx-YecxhPgxEBBL3WygBp3R1fzgtCiUZLNB-Rpqw8130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591155.RADdlx-YecxhPgxEBBL3WygBp3R1fzgtCiUZLNB-Rpqw8130_provenance.
- NP591141.RAZP6wm2NrTBGF9uNnR3K2VjKM4on53tJfWLSrPCtRwmk130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591141.RAZP6wm2NrTBGF9uNnR3K2VjKM4on53tJfWLSrPCtRwmk130_provenance.
- NP591145.RAT93hgW4PPy4aA1pgKRRyY5gJTFzUD3C5M4HyyeLDcqI130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591145.RAT93hgW4PPy4aA1pgKRRyY5gJTFzUD3C5M4HyyeLDcqI130_provenance.
- NP591156.RAdI48vUg5ZbUYoM3n9vkhhlTjs2T2NR6JT4Regg9gIwA130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591156.RAdI48vUg5ZbUYoM3n9vkhhlTjs2T2NR6JT4Regg9gIwA130_provenance.
- NP698178.RAjRbumFCizCA6IPPqZoEktxhuQimIAQYLtxrl-lbgIEk130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698178.RAjRbumFCizCA6IPPqZoEktxhuQimIAQYLtxrl-lbgIEk130_provenance.
- NP217402.RA-jBQ8x7IepBz3vS-Ztk0R_fuvRoOhxxikngDj4dGHy4130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217402.RA-jBQ8x7IepBz3vS-Ztk0R_fuvRoOhxxikngDj4dGHy4130_provenance.
- NP591152.RApxLke4UKD_Fhd98AYVBKiZjr7gyQtoxBUm249wxq0hI130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591152.RApxLke4UKD_Fhd98AYVBKiZjr7gyQtoxBUm249wxq0hI130_provenance.
- NP372578.RAMM012HjCxJALBigZ6Wsv-1mwZ7jYY20WVzTo1TNSgSY130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372578.RAMM012HjCxJALBigZ6Wsv-1mwZ7jYY20WVzTo1TNSgSY130_provenance.
- NP591153.RAG50YKXQcwNrOnPbC4uqe-ES_uWm_5TVvT9M8Ne7O6HA130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591153.RAG50YKXQcwNrOnPbC4uqe-ES_uWm_5TVvT9M8Ne7O6HA130_provenance.
- NP974408.RA5f2Vld1BxhUwNR1YoFjyTs6_frjfAP8MlpfdY_w1mHM130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974408.RA5f2Vld1BxhUwNR1YoFjyTs6_frjfAP8MlpfdY_w1mHM130_provenance.
- NP591148.RAyvg51Ul7UaROF_0oK19sgyGiYoQcLxTjv_g3Hbquek8130_assertion description "[Phenotypes reconstructed after haplotype analyses showed that the carriers of the combined NAT1 fast+ NAT2 fast phenotypes were at lower risk when compared with those with the combined NAT1 slow + NAT2 slow acetylator phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591148.RAyvg51Ul7UaROF_0oK19sgyGiYoQcLxTjv_g3Hbquek8130_provenance.